
ERS Genomics & Demeetra Enter Into CRISPR/Cas9 Licensing Agreement
ERS Genomics & Demeetra Enter Into CRISPR/Cas9 Licensing Agreement Demeetra to broaden synthetic biology and bioprocessing technology through combined CRISPR/Cas9 IP and Demeetra’s own dimeric…